Document Detail

Malaria and Fetal Growth Alterations in the 3(rd) Trimester of Pregnancy: A Longitudinal Ultrasound Study.
Jump to Full Text
MedLine Citation:
PMID:  23326508     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Pregnancy associated malaria is associated with decreased birth weight, but in-utero evaluation of fetal growth alterations is rarely performed. The objective of this study was to investigate malaria induced changes in fetal growth during the 3(rd) trimester using trans-abdominal ultrasound.
METHODS: An observational study of 876 pregnant women (398 primi- and secundigravidae and 478 multigravidae) was conducted in Tanzania. Fetal growth was monitored with ultrasound and screening for malaria was performed regularly. Birth weight and fetal weight were converted to z-scores, and fetal growth evaluated as fetal weight gain from the 26th week of pregnancy.
RESULTS: Malaria infection only affected birth weight and fetal growth among primi- and secundigravid women. Forty-eight of the 398 primi- and secundigravid women had malaria during pregnancy causing a reduction in the newborns z-score of -0.50 (95% CI: -0.86, -0.13, P = 0.008, multiple linear regression). Fifty-eight percent (28/48) of the primi- and secundigravidae had malaria in the first half of pregnancy, but an effect on fetal growth was observed in the 3(rd) trimester with an OR of 4.89 for the fetal growth rate belonging to the lowest 25% in the population (95%CI: 2.03-11.79, P<0.001, multiple logistic regression). At an individual level, among the primi- and secundigravidae, 27% experienced alterations of fetal growth immediately after exposure but only for a short interval, 27% only late in pregnancy, 16.2% persistently from exposure until the end of pregnancy, and 29.7% had no alterations of fetal growth.
CONCLUSIONS: The effect of malaria infections was observed during the 3(rd) trimester, despite infections occurring much earlier in pregnancy, and different mechanisms might operate leading to different patterns of growth alterations. This study highlights the need for protection against malaria throughout pregnancy and the recognition that observed changes in fetal growth might be a consequence of an infection much earlier in pregnancy.
Christentze Schmiegelow; Daniel Minja; Mayke Oesterholt; Caroline Pehrson; Hannah Elena Suhrs; Stéphanie Boström; Martha Lemnge; Pamela Magistrado; Vibeke Rasch; Birgitte Bruun Nielsen; John Lusingu; Thor G Theander
Related Documents :
8546048 - Thyroid disease during pregnancy.
16487888 - Cosmetic aspects of pregnancy.
15074368 - Iodine deficiency in pregnant women and in their neonates in the central anatolian regi...
16420328 - A screening for the occurrence of autoreactive antibodies in sera of pregnant and non-p...
21463428 - Successful recovery from delayed amniotic fluid embolism with prolonged cardiac resusci...
7202738 - The conservative surgical treatment of endometriosis: evaluation of pregnancy success w...
Publication Detail:
Type:  Journal Article     Date:  2013-01-11
Journal Detail:
Title:  PloS one     Volume:  8     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e53794     Citation Subset:  IM    
Centre for Medical Parasitology, Institute of International Health, Immunology, and Microbiology, University of Copenhagen, Copenhagen, Denmark ; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
ISSN: 1932-6203
Publisher: Public Library of Science, San Francisco, USA
Article Information
Download PDF
Copyright: 2013 Schmiegelow et al
Received Day: 24 Month: 9 Year: 2012
Accepted Day: 3 Month: 12 Year: 2012
collection publication date: Year: 2013
Electronic publication date: Day: 11 Month: 1 Year: 2013
Volume: 8 Issue: 1
E-location ID: e53794
PubMed Id: 23326508
ID: 3543265
Publisher Id: PONE-D-12-29446
DOI: 10.1371/journal.pone.0053794

Malaria and Fetal Growth Alterations in the 3rd Trimester of Pregnancy: A Longitudinal Ultrasound Study Alternate Title:Malaria and Fetal Growth Alterations
Christentze Schmiegelow18*
Daniel Minja128
Mayke Oesterholt3
Caroline Pehrson148
Hannah Elena Suhrs18
Stéphanie Boström5
Martha Lemnge2
Pamela Magistrado18
Vibeke Rasch6
Birgitte Bruun Nielsen7
John Lusingu128
Thor G. Theander18
François Nostenedit1 Role: Editor
1Centre for Medical Parasitology, Institute of International Health, Immunology, and Microbiology, University of Copenhagen, Copenhagen, Denmark
2National Institute for Medical Research, Tanga Medical Research Center, Tanga, Tanzania
3Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
4Department of Public Health, University of Copenhagen, Copenhagen, Denmark
5Department of Immunology, Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
6Department of Obstetrics and Gynecology, Odense University Hospital, Odense, Denmark
7Department of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark
8Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark
Mahidol University, Thailand
Correspondence: * E-mail:
[conflict] Competing Interests: The authors have declared that no competing interests exist.
Contributed by footnote: Contributed to writing the manuscript: CS DM MO CP HES SB ML PM VR BBN JL TGT. Approved the final version of the manuscript: CS DM MO CP HES SB ML PM VR BBN JL TGT. Conceived and designed the experiments: CS ML VR JL TGT BBN. Performed the experiments: CS DM MO CP HES SB PM JL. Analyzed the data: CS BBN TGT. Wrote the paper: CS.


Pregnancy associated malaria (PAM) caused by Plasmodium falciparum is associated with maternal anemia [1], stillbirth [2], preterm delivery [3], [4] and decreased birth weight (BW) [3][7]. Furthermore, PAM might have long-term health consequences for the newborn due to an increased risk of non-communicable diseases among adults born with low birth weight (BW<2500 g) (LBW) and poor intrauterine growth [8], [9]. Maternal immunity to PAM is acquired after malaria infections over consecutive pregnancies leaving women in their first pregnancies most at risk [1], [10], [11]. P. falciparum invades the erythrocytes, and the effect on BW has been attributed to maternal anemia [5], [12] and the sequestration of infected erythrocytes in the placenta [13][17]. It is still unknown, when during pregnancy the woman and fetus are most vulnerable to PAM [7], [18][23]. However, many studies indicate that the first half of pregnancy is a particularly vulnerable period [7], [18][20], [22], [23], but little is known of when and how fetal growth is affected. LBW is used as a measure of the consequence of PAM [4], [18], [19], [21], but this is misleading as an indicator of altered fetal growth since LBW encompasses both newborns having suffered poor intrauterine growth as well as preterm newborns without growth impairment [24]. A better way to evaluate fetal growth is therefore to report individual changes over time expressed as z-score changes (deviation of weight from the gestational age (GA) adjusted mean) [25], [26] or fetal weight gain [27], [28].

To ensure that preventive strategies are targeting the most vulnerable time-points in pregnancy a better understanding of fetal growth alterations after PAM is warranted [10]. The objective of this study was to investigate the effect of PAM on fetal growth in the late half of pregnancy by using trans-abdominal ultrasound among a cohort of pregnant women in northeastern Tanzania. We here present evidence of fetal growth alteration in the 3rd trimester of pregnancy after a malaria infection.


Ethical approval was granted by the Tanzania Medical Research Coordinating Committee (MRCC) (18th of April 2008, reference number NIMR7HQ/R.8a/Vol. IX/688). All procedures were conducted in accordance with the Declaration of Helsinki and Good Clinical and Laboratory Practices. All participants gave informed written consent.

The study was conducted in Korogwe District, northeastern Tanzania. Malaria transmission is holoendemic, but has lately shown a remarkable decline [29]. Pregnant women attending the Reproductive and Child Health clinic of Korogwe District Hospital (KDH) or the Lwengera, Kerenge and Ngombezi Dispensaries were enrolled from September 2008 until March 2010 and followed throughout pregnancy. The last delivery occurred in October 2010. The study design has been reported previously [30], [31]. In short, inclusion criteria were: GA≤24 weeks determined by ultrasound, living in an accessible area of Korogwe District for >6 months, and willing to give birth at KDH. Women with preeclampsia and/or twins in the current pregnancy, and fetuses/newborns with severe malformations were excluded from the analysis, since these conditions can severely affect fetal growth [32], [33]. In analyses including BW, stillbirths were omitted. Sensitization campaigns were performed in the villages to reduce selection bias. After inclusion, women were booked for three antenatal visits (ANV) at a GA of 26 (ANV2), 30 (ANV3), and 36 (ANV4) weeks. If needed due to illness women attended extra clinic visits. Maternal age, anthropometric measures, obstetric history, educational level (≤primary school; ≥secondary school), HIV status, and hemoglobin level (Sysmex hematological analyzer®, Kobe, Japan) were documented. The project team performed all investigations except screening for maternal HIV infection which governmental nurses performed only three days a week. Women not completing follow-up were therefore less likely to have their HIV status determined. Transport was offered at the time of delivery and 77.2%, 5.3%, and 17.6% delivered at KDH, another health facility, and at home, respectively. Home visits were performed within one week of the bookings or the estimated date of delivery, if women failed to report at KDH.

At all visits venous blood was collected and at delivery both venous and placental blood. Malaria was diagnosed using rapid diagnostic test (RDT) (Parascreen™ Zephyr Biomedicals, Goa, India, Paracheck Pf® Orchid Biomedical Systems, Goa, India or ParaHIT® Span diagnostics Ltd, Surat, India) [34]. Thick and thin blood smears were prepared and evaluated at the end of the study. Women were therefore treated based on the RDT results with Artemether-Lumefantrine (Coartem® Dispersible, Norvatis Corporation Suffern, New York, USA) or Quinine (Quinine sulfate coated tablets, ELYS chemical Industries Ltd, Nairobi, Kenya) (infections occurring in 1st trimester). Women with symptoms or sign of malaria had an immediate blood smear investigation in addition to the RDT. Infections requiring hospital admission were treated with Quinine (Quinine Dihydrochloride Injection BP, Healthcare PVT Ltd, Mumbai India). RDT positive women, who had been RDT positive within two weeks before the ANV, also had an immediate blood smear examination. Parasite HRP-2 antigen can circulate in the blood stream after clearance of the malaria parasites, and only women who were consistently blood smear positive were treated [35]. Blood smears were stained with Giemsa, and asexual parasites counted against 200 (500 if parasite count was <10) leucocytes. One hundred thick film fields were read before a slide was declared negative. The malaria infection was considered symptomatic if the axillary temperature was above 37.5C.

Intermittent preventive treatment for malaria (IPTp) with sulfadoxine-pyrimethamine (1500 mg/75 mg) (SULPHADAR®, Shelys Pharmaceutical Ltd., Dar es Salaam, Tanzania) was given as directly observed treatment; 1st dose in the 2nd trimester after a GA of 20 weeks and 2nd dose in the 3rd trimester, at least four weeks apart. If included early in pregnancy the 1st dose was given at an extra clinic visit at a GA of 20. If having received a 1st dose of IPTp before inclusion, but earlier than recommended by WHO (2nd trimester when quickening is felt [36]), the woman received a 2nd dose at week 20 and a 3rd dose in the 3rd trimester. According to the national program, voucher for procuring a bednet was provided and bednet use inquired.

Trans-abdominal ultrasound examination was performed at inclusion, ANV2, ANV3, and ANV4 (Sonosite TITAN®, US High resolution ultrasound system, 5–2 MHz C60 abdominal probe, Bothell, Washington state, USA). At inclusion GA was estimated using crown-rump length (crown-rump length<75 mm) [37]) or head circumference of the fetus [38]. If the GA was <11 weeks a new GA estimation was performed at 11–16 weeks of gestation. At ANV2, 3, and 4 fetal weight (EFW) were estimated using the Hadlock algorithms based on head circumference, abdominal circumference and femur length [39]. The performance of the Hadlock algorithms in this population has been reported previously [31]. All investigations were performed by the author CS, assisted by a trained Tanzanian midwife.

To account for dependency of growth velocity on initial weight, fetal growth was evaluated as the relative weight gain in g/week*kg in four fixed growth intervals of at least 14 days [28], [40] representing different time-points in pregnancy (ANV2-ANV3 (late 2nd trimester/); ANV3-ANV4 (early 3rd trimester); ANV4-Delivery (late 3rd trimester); ANV3-Delivery (entire 3rd trimester)) using the fetal weight (kg) in the beginning of each growth interval as the reference [27], [28], [41]. Relative weight gain was furthermore dichotomized as the lowest 25% or the highest 75%. At delivery BW, head and abdominal circumference, sex, and placental weight were documented. BW measured within 24 hours of delivery using a spring scale (Fazzini®, accuracy = 50 g, Vimodrone, Italy) (KDH, until July 2009 and all examinations at home) or a digital strain gauge scale (ADE®, accuracy = 10 g, Hamburg, Germany) (KDH, after July 2009) were considered eligible.

To exclude variability due to GA and sex, EFW and BW were converted to z-scores using sex-specific standard weight charts developed from healthy pregnancies in the same cohort as a reference [31].

Changes in z-score over time were investigated to further evaluate alterations in fetal growth. Only offspring with an eligible BW and data from at least two growth intervals were evaluated. Primarily, the growth intervals ANV2-ANV3, ANV3-ANV4, ANV4-Delivery were used for evaluation. Alternative growth intervals (ANV2-ANV4, ANV3-Delivery) were used if a woman had incomplete attendance. Changes in z-scores (Δz) were calculated for the malaria negative group and used as a reference. Theoretically, a normally growing fetus will have a Δz close to zero, whereas a Δz>0 represents excess fetal weight gain and a Δz<0 insufficient weight gain. Evaluation of changes in z-scores can be affected by the fetal pulsatile growth pattern [42] and to limit false-positives the 25th centile for Δz was used as a cut-off to define insufficient weight gain. The effect of malaria was categorized in four groups: 1) Normal growth as Δz ≥25th centile in all growth intervals following a malaria infection, 2) Immediate effect as Δz <25th centile in the growth interval when the infection occurred or in the first growth interval after a malaria infection, followed by growth intervals where Δz ≥25th centile, 3) Late effect as a Δz<25th centile in a growth interval not immediately following the infection, and 4) Persistent effect as a Δz <25th centile immediately after a malaria infection and until the end of pregnancy.

For analysis, women were considered to be malaria negative if they never had malaria based on RDT and microscopy results from the time they were enrolled. Women, who contracted malaria (RDT and/or microscopy positive), were considered to belong to the malaria group from when they were diagnosed until delivery. In growth intervals preceding the time of detection of the malaria infection they were excluded from the analysis. Hence, women contracting malaria between ANV2 and ANV3 were not included in analyses of the growth interval ANV2-ANV3, but considered malaria positive in all other growth intervals.


All data were documented and validated using Microsoft Office Access 2003. Statistical analyses were performed in Stata 10 (Stata Corporation) using, when appropriate, Chi2 test, Fisher’s exact test, Mann Whitney ranksum, and Student t-test, and all with two-sided P-values. The effect of malaria on BW (as z-score) was investigated using multiple linear regression and on relative weight gain (dichotomized as lowest 25% and highest 75%) using multiple logistic regression. Crude and adjusted coefficients/odds ratios were calculated. Factors with a P<0.20 in univariate analysis were entered into the multivariate models. Using a step-wise backward elimination approach final models were obtained including variables with a P<0.10. A P<0.05 was considered significant. Final models only included women without missing values.


In total, 1171 pregnant women were screened and 995 women met the inclusion criteria. Of these 21 women had miscarriage, 11 withdrew consent, 34 were lost to follow-up, 5 moved out of the district, and 924 women completed follow-up. Of these, 48 were excluded due to (some with multiple conditions) preeclampsia (28), twin pregnancy (16), and/or severe congenital malformation (6), leaving 876 women-newborn pairs for analysis. The included women were more often multigravidae, had a known HIV status and lower educational level compared to the excluded women (Supplementary Table 1). In total, 18 stillbirths occurred.

Characteristics of the 876 mother-newborn pairs are shown in Table 1 and 2. In total, 398 primi- and secundigravidae and 478 multigravidae completed follow-up. Malaria during pregnancy was diagnosed in 8.2% (72/876) of the women, and was more common among primi- and secundigravidae than among multigravidae (P<0.001, Chi 2 test) (Table 1). Except for rarer use of bednets (primi- and secundigravidae) and IPTp (multigravidae), higher risk of anemia (primi- and secundigravidae) and lower placental weight (primi- and secundigravidae) there were no difference in baseline characteristics between the malaria positive and negative groups (Supplementary Table S2 and S3). None of the multigravidae, and six of the primi- and secundigravidae had a symptomatic malaria infection. Hereof, three women were admitted to the hospital for treatment. In total, 40 women were slide positive at some point and 32 women were only RDT positive but never slide positive. Among the women who were slide positive, five primi- and secundigravidae were RDT negative, and hence not treated for their malaria infection, because microscopy were performed retrospectively. None of these women were RDT positive at any of the consecutive visits. Six women (four primigravidae and two multigravidae) were RDT positive, but microscopy negative, within 14 days of treatment for their initial malaria infection and were not treated again. Details on the malaria infections are given in Table 1 and characteristics of all malaria positive women are available as Supplementary Table S4.

The majority of ANV2, 3 and 4 was conducted at a GA of 26 (698/843 (82.3%) estimated fetal weights (EFW)), 30 (727/837 (86.9%) EFW) and 36 (688/792 (86.9%) EFW) weeks, respectively. Women showing early or late for their bookings had fetal weight estimated within 1.5 weeks of these GA. The timing of the ANV was comparable for the malaria positive and malaria negative women (Supplementary Table S2 and S3).

Among primi- and secundigravidae malaria infection resulted in a decrease in median BW (2910 g (malaria positive) vs. 3100 g (malaria negative), P = 0.005, Mann-Whitney), whereas malaria infection did not affect the BW among multigravidae. Furthermore, the newborns Z-score on BW was statistically significant lower among the malaria positive compared to the malaria negative primi- and secundigravidae (−0.63 (malaria positive) vs. −0.06 (malaria negative), P = 0.003, Students t-test). Malaria infection did not affect the GA at delivery (Table 2).

Alterations in fetal growth patterns following malaria infections were further investigated among primi-and secundigravidae by evaluating the relative fetal weight gain in the four growth intervals in the late half of pregnancy (ANV2-ANV3, ANV3-ANV4, ANV4-Delivery, ANV3-Delivery) (Table 3). In univariate analyses relative fetal weight gain was statistical significantly reduced in the 3rd trimester of pregnancy in the malaria positive group compared to the malaria negative group. The relative weight gain had unequal variance and we therefore dichotomized the women into those with a relative fetal weight gain belonging to the lowest 25% and those with a weight gain belonging to the highest 75%, to allow adjusting for confounding factors using multiple logistic regression. In the 3rd trimester, in the univariate analyses, there were a statistical significantly higher proportion of fetuses belonging to the lowest 25% among the malaria positive compared to the malaria negative group (Table 4). Fetal growth is affected by maternal anthropometry and fetal sex [42][44]. We therefore investigated the effect of malaria on fetal growth and BW after adjusting for possible confounding factors (Table 5). The characteristics listed in Table 1, GA at the ANVs and at delivery and place of delivery were evaluated as possible confounding factors (Supplementary Table S5 and S6). After adjustment, Z-score at birth was still affected by malaria with a decrease in z-score of −0.50 after exposure (95% CI: −0.86, −0.13; P = 0.008, multiple linear regression). Malaria infection was also associated with a relative fetal weight gain belonging to the lowest 25% in all three growth intervals in the 3rd trimester after adjusting for confounding factors (ANV3-ANV4 adj. odds ratio (OR): 2.72, 95% CI: 1.18–6.23, P = 0.019; ANV4-Delivery adj. OR: 2.48, 95% CI: 1.04–5.91, P = 0.040; ANV3-Delivery adj. OR: 4.89, 95% CI: 2.03–11.79, P<0.001) (Table 5). Only considering women with a single infection, adjusting for number of infections, or excluding women who did not receive malaria treatment did not alter the results (data not shown).

To further elucidate how and when fetal growth in the last half of pregnancy was affected by malaria we evaluated the change in z-score over time. To illustrate the importance of gravidity when assessing the consequences of malaria on fetal growth multigravidae were also included in these analyses. Fifty-two of the 72 women (72.2%) with malaria had an eligible BW and data available for at least two growth intervals. Among the primi- and secundigravid women, the majority (26/37) experienced alterations in fetal growth after a malaria infection. An equal distribution between an immediate, a late and a persistent effect on fetal growth was observed. Among the majority of the multigravid women (10/15) the fetal growth was not affected. Furthermore, a persistent and a late alteration of fetal growth seemed to result in the lowest BW (Table 6). In Figure 1 examples of different growth patterns are illustrated.

Among primi- and secundigravidae, there was a trend towards decreased head circumference at birth (Supplementary Table S2), decreased fetal abdominal growth from ANV3-Delivery, and decreased growth of the fetal head from ANV2-ANV3 and ANV3-ANV4 in the malaria positive compared to the malaria negative group (data not shown).


This study provides one of the first comprehensive analyses of fetal growth alterations associated with PAM by using ultrasound.

Malaria infections affected fetal growth among primi- and secundigravidae. Many studies report that primigravid women experience the most severe consequences of PAM [5], [45]. Malaria transmission has dramatically declined over the last years in the study area [29] and this might explain why also secundigravidae were of increased risk. More importantly, fetal growth was still altered after malaria infection despite the fact that RDT positive women were treated for malaria and more than 96% of all the women received at least two doses of IPTp. Women were considered as having been exposed to malaria if they had a positive RDT even though they were negative by microscopy. These samples have subsequently been analyzed by PCR [35]. Among primi- and secundigravidae eight were positive by RDT and negative by PCR (Supplementary Table S4). Excluding these women from the analyses or considering them as malaria negative did not alter the results (data not shown).

The relative fetal weight gain was significantly decreased among malaria positive primi- and secundigravidae compared to uncomplicated pregnancies. The effect of malaria was observed regardless of whether early, late, or the entire 3rd trimester was evaluated. Furthermore, the newborns’ z-score was significantly decreased among the malaria exposed compared to the unexposed, indicating that a disproportional change in growth velocity occurred in the 3rd trimester leading to the PAM induced decrease in BW previously reported [3][7]. Although, the decrease only was statistically significant in the 3rd trimester, the data (Table 3) indicates that fetal growth was also decreased in late 2nd trimester and that there might be trend of increasing difference in fetal growth over time, but this could not be confirmed statistically. Rijken et al[46] showed that malaria can cause growth restriction in the 2nd trimester. This could cause an underestimation of the GA in the malaria positive group resulting in a less apparent effect of malaria on growth. This as well as the size of the study might have resulted in insufficient statistical power to detect a difference in late 2nd trimester. Malaria was not associated with perinatal mortality [30], and stillborns were excluded from analyses were BW were included. Abnormal fetal growth resulting in stillbirth should therefore not have affected the results.

Upon investigating the individual alterations in fetal growth after malaria exposure, four distinct patterns were identified. Again, the most pronounced effect was observed among primi- and secundigravidae. Our results indicated that late and persistent alterations resulted in the lowest BW. The sample size was limited, and these results will need to be confirmed in future studies.

Most infections in our cohort were detected at inclusion (1st and 2nd trimester). Previous findings indicate that the timing of the infection matters [7], [18][22], with early infections being more harmful than late [7], [18][20], [22], [23]. In the 1st and 2nd trimester the placental development is particularly sensitive to pathology, and if the trophoblast invasion of the maternal spiral arteries are disrupted, current and later placental function can be impaired [47]. PAM has been speculated to disrupt trophoblast invasion [16], [17] and been associated with decreased placenta volume [48] and changes in utero-placental and umbilical blood flow [13], [49]. Sequestration of infected erythrocytes can also cause impaired placental function due to an inflammatory response and structural [15] as well as functional changes of the syncytiotrophoblast layer [14], [16]. A recent study by Griffin et al[49] reported changes in umbilical blood flow in the 3rd trimester after infections occurring before a GA of 20 weeks. This indicates that the effect of PAM might be observed with considerable delay, which is in line with the pattern observed in our study. In the 3rd trimester when nutrient requirement of the fetus is at its highest level, insufficient placental development and function could have severe consequences [16], [47]. Histopathological data of the placenta was not available in this study, but our data indicate that different mechanisms operate in different individuals leading to none, immediate, late or persistent alteration of fetal growth. Further investigations of the women’s immunological profiles and studies combining in-utero monitoring of fetal growth with histopathological investigations might clarify why different growth alterations arise. Partial immunity could explain some of the variation in the growth alterations after malaria infections.

Among the primi- and secundigravidae the majority of the infections were detected at the time of inclusion or just hereafter, and before the first dose of IPTp (Supplementary Table S4). A recent study provided evidence that IPTp administered early during pregnancy is more protective of LBW than late administration [50]. This and the current study highlights the importance of prescribing IPTp as early as possible, and the importance of identifying interventions that can diminish the risk of infection before the first antenatal visit. Alternatively, efforts should concentrate on promoting early antenatal attendance employing the current preventive measures with a “diagnose and treat” approach.

Infection with malaria prior to inclusion in the study might affect fetal growth, but reliable data on this was not available. However, including GA at inclusion in the multiple regression models did not alter the results (data not shown). In future studies, inclusion as soon as possible after conceiving should be sought. Furthermore, maternal HIV infection might also affect fetal growth [51]. The prevalence of maternal HIV infection was low in our population and did not significantly alter BW (data not shown). In areas with higher prevalence, HIV might modify the effect of malaria on fetal growth, and this should be considered in future studies.

We investigated malaria induced changes in fetal growth using both a reference population and each individual fetus as his/her own control. This approach enabled us to capture changes that may not cause LBW, but do hinder the newborn in obtaining its inherent growth potential. By utilizing ultrasound to estimate GA and a local standard weight chart for reference we circumvented some of the difficulties encountered in previous malaria studies on assessment of intrauterine growth [10], [16]. Previously, alterations in fetal growth have been evaluated using neonatal anthropometry [5], [51] or small-for-gestational-age [3], [52] as proxy measures of intrauterine growth retardation. Few previous studies have utilized ultrasound to evaluate the effect of malaria on fetal growth. One study in Congo [49], [53] showed an association between PAM and in-utero small-for-gestational-age, and a study from the Thai-Burmese border reported a decrease in fetal biparietal diameter after malaria infection [46].

To validate our ultrasound data we investigated the correlation between fetal weight gain in the different growth intervals and BW, independent of malaria infection, and found a significant correlation (data not shown). Alterations in fetal growth has been evaluated using changes in z-scores [25], [26], weight gain in grams [27], [28], or fetal abdominal circumference association with later intrauterine growth retardation [41], [54], but consensus on the best method is still to be reached. We therefore decided to combine relative weight gain and changes in z-score to evaluate the effect of PAM in our population.

One limitation of the study was that the ultrasonographs were not blinded to the women’s current or previous malaria status. Furthermore, we did not observe consistent statistically significant changes in head and abdominal circumference. This might be due the possibly decrease in accuracy when estimating fetal size using single biometric parameters [55][57].

In conclusion, we provide evidence that alteration of fetal growth after P. falciparum malaria exposure can be observed in the 3rd trimester. The effects on fetal growth often occurred after a considerable delay in women who were diagnosed with malaria at the first antenatal visit and who subsequently strictly followed the antenatal program and the recommended measures to prevent malaria infections. The study was carried out in an area where malaria transmission has declined considerably and the results highlight the importance of developing interventions which can protect women early in pregnancy.

Supporting Information Table S1

Comparison of included and excluded mother-newborn pairs.


Click here for additional data file (pone.0053794.s001.docx)

Table S2

Comparison of characteristics for malaria positive and malaria negative primi- and secundigravid mothers and their fetuses/newborns.


Click here for additional data file (pone.0053794.s002.docx)

Table S3

Comparison of characteristics for malaria positive and malaria negative multigravid mothers and their fetuses/newborns.


Click here for additional data file (pone.0053794.s003.docx)

Table S4

Characteristics of all malaria positive women.


Table S5

Factors associated with 3rd trimester relative fetal weight gain ((g/week)*kg) dichotomized as belonging to the lowest 25% or the highest 75% for primi- and secundigravidae.


Click here for additional data file (pone.0053794.s005.docx)

Table S6

Factors associated Z-score at delivery among primi- and secundigravidae. Z-score was adjusted for sex of newborn and gestational age at delivery.


Click here for additional data file (pone.0053794.s006.docx)

First and foremost we would like to thank our study participants. We would also like to thank all STOPPAM staff in Tanzania (Sophia Kabome, Francis Assenga, Charles Tunuka, Lydia Massawe, Halima Mpambile, Rose Mutua, Aziz Seiph, Latifa Shaweji, Prisca Mavindi, Pernille Kofoed, Line Holm, Martyna Gassowski, Peter Cordes, Tilaus Gustav, Deusdedith Makingi, Thomson Mwampamba, Silas Msangi, Stella Andrew, Eva Rimoy, Christopher Mhagama, Francis Mkongo, Allen Mrango, Hassan Kilavo, and Christopher Masaka). Special gratitude is given to Lydia Massawe for assistance in conducting the ultrasound investigations, and Professor Thomas Scheike at the Biostatistic Department, Institute of Public Health, University of Copenhagen for consultancy on the statistical analyses. Finally, we acknowledge the STOPPAM consortium, NIMR-Tanga Center, Joint Malaria Programme, the administration at Korogwe District hospital and the NIMR Director General for granting us permission to publish.

This manuscript follows the STROBE guidelines.

1. Shulman CE,, Marshall T,, Dorman EK,, Bulmer JN,, Cutts F,, et al. (Year: 2001) Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health6: 770–77811679125
2. Ishaque S,, Yakoob MY,, Imdad A,, Goldenberg RL,, Eisele TP,, et al. (Year: 2011) Effectiveness of interventions to screen and manage infections during pregnancy on reducing stillbirths: a review. BMC Public Health11 Suppl 3S321501448
3. Sullivan AD,, Nyirenda T,, Cullinan T,, Taylor T,, Harlow SD,, et al. (Year: 1999) Malaria infection during pregnancy: intrauterine growth retardation and preterm delivery in Malawi. J Infect Dis179: 1580–158310228088
4. Steketee RW,, Wirima JJ,, Hightower AW,, Slutsker L,, Heymann DL,, et al. (Year: 1996) The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg55: 33–418702035
5. Meuris S,, Piko BB,, Eerens P,, Vanbellinghen AM,, Dramaix M,, et al. (Year: 1993) Gestational malaria: assessment of its consequences on fetal growth. Am J Trop Med Hyg48: 603–6098517479
6. Verhoeff FH,, Brabin BJ,, van BS,, Chimsuku L,, Kazembe P,, et al. (Year: 2001) An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin Nutr55: 682–68911477467
7. Huynh BT,, Fievet N,, Gbaguidi G,, Dechavanne S,, Borgella S,, et al. (Year: 2011) Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg85: 214–22021813837
8. Claris O,, Beltrand J,, Levy-Marchal C, (Year: 2010) Consequences of intrauterine growth and early neonatal catch-up growth. Semin Perinatol34: 207–21020494737
9. Christensen DL,, Kapur A,, Bygbjerg IC, (Year: 2011) Physiological adaption to maternal malaria and other adverse exposure: low birth weight, functional capacity, and possible metabolic disease in adult life. Int J Gynaecol Obstet115 Suppl 1S16–S1922099434
10. Rogerson SJ,, Mwapasa V,, Meshnick SR, (Year: 2007) Malaria in pregnancy: linking immunity and pathogenesis to prevention. Am J Trop Med Hyg77: 14–2218165470
11. Desai M,, Ter Kuile FO,, Nosten F,, McGready R,, Asamoa K,, et al. (Year: 2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis7: 93–10417251080
12. Mahajan S,, Aalinkeel R,, Shah P,, Singh S,, Gupta N,, et al. (Year: 2008) Nutritional anaemia dysregulates endocrine control of fetal growth. Br J Nutr100: 408–41718272016
13. Dorman EK,, Shulman CE,, Kingdom J,, Bulmer JN,, Mwendwa J,, et al. (Year: 2002) Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol19: 165–17011876809
14. Umbers AJ,, Boeuf P,, Clapham C,, Stanisic DI,, Baiwog F,, et al. (Year: 2011) Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis203: 561–56921216864
15. Rogerson SJ,, Pollina E,, Getachew A,, Tadesse E,, Lema VM,, et al. (Year: 2003) Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg68: 115–11912556159
16. Umbers AJ, Aitken EH, Rogerson SJ (2011) Malaria in pregnancy: small babies, big problem. Trends Parasitol.
17. Muehlenbachs A,, Mutabingwa TK,, Edmonds S,, Fried M,, Duffy PE, (Year: 2006) Hypertension and maternal-fetal conflict during placental malaria. PLoS Med3: 2124–2130
18. Taha TT,, Gray RH,, Mohamedani AA, (Year: 1993) Malaria and low birth weight in central Sudan. Am J Epidemiol138: 318–3258356970
19. Kalilani L,, Mofolo I,, Chaponda M,, Rogerson SJ,, Meshnick SR, (Year: 2010) The effect of timing and frequency of Plasmodium falciparum infection during pregnancy on the risk of low birth weight and maternal anemia. Trans R Soc Trop Med Hyg104: 416–42220207387
20. Rogerson SJ,, van den Broek NR,, Chaluluka E,, Qongwane C,, Mhango CG,, et al. (Year: 2000) Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg62: 335–34011037774
21. Cottrell G,, Mary JY,, Barro D,, Cot M, (Year: 2007) The importance of the period of malarial infection during pregnancy on birth weight in tropical Africa. Am J Trop Med Hyg76: 849–85417488903
22. Valea I,, Tinto H,, Drabo MK,, Huybregts L,, Sorgho H,, et al. (Year: 2012) An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso. Malar J11: 7122433778
23. McGready R, Lee S, Wiladphaingern J, Ashley E, Rijken M et al. . (2011) Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis.
24. Wilcox AJ, (Year: 2001) On the importance–and the unimportance–of birthweight. Int J Epidemiol30: 1233–124111821313
25. Mondry A,, Pengbo L,, Loh M,, Mongelli M, (Year: 2005) Z-velocity in screening for intrauterine growth restriction. Ultrasound Obstet Gynecol26: 634–63816254884
26. Chang TC,, Robson SC,, Spencer JA,, Gallivan S, (Year: 1993) Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight. Obstet Gynecol82: 230–2368336870
27. Hemachandra AH,, Klebanoff MA, (Year: 2006) Use of serial ultrasound to identify periods of fetal growth restriction in relation to neonatal anthropometry. Am J Hum Biol18: 791–79717039476
28. de Jong CL,, Francis A,, van Geijn HP,, Gardosi J, (Year: 1999) Fetal growth rate and adverse perinatal events. Ultrasound Obstet Gynecol13: 86–8910079485
29. Mmbando BP,, Vestergaard LS,, Kitua AY,, Lemnge MM,, Theander TG,, et al. (Year: 2010) A progressive declining in the burden of malaria in north-eastern Tanzania. Malar J9: 216–22420650014
30. Schmiegelow C,, Minja D,, Oesterholt M,, Pehrson C,, Suhrs HE,, et al. (Year: 2012) Factors associated with and causes of perinatal mortality in northeastern Tanzania. Acta Obstet Gynecol Scand91: 1061–106822676243
31. Schmiegelow C, Scheike T, Oesterholt M, Minja D, Pehrson C et al. . (2012) Development of a Fetal Weight Chart Using Serial Trans-Abdominal Ultrasound in an East African Population: A Longitudinal Observational Study. PLoS ONE 7: doi:10.1371/journal.pone.0044773.
32. Hendrix N,, Berghella V, (Year: 2008) Non-placental causes of intrauterine growth restriction. Semin Perinatol32: 161–16518482615
33. Kramer MS, (Year: 2003) The epidemiology of adverse pregnancy outcomes: an overview. J Nutr133: 1592S–1596S12730473
34. Kyabayinze DJ,, Tibenderana JK,, Nassali M,, Tumwine LK,, Riches C,, et al. (Year: 2011) Placental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting. Malar J10: 30622004666
35. Minja DT,, Schmiegelow C,, Oesterholt M,, Magistrado PA,, Bostrom S,, et al. (Year: 2012) Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. Malar J11: 21122720788
36. World Health Organisation (2010) World Malaria Report.
37. Hadlock FP,, Shah YP,, Kanon DJ,, Lindsey JV, (Year: 1992) Fetal crown-rump length: reevaluation of relation to menstrual age (5–18 weeks) with high-resolution real-time US. Radiology182: 501–5051732970
38. Chitty LS,, Altman DG,, Henderson A,, Campbell S, (Year: 1994) Charts of fetal size: 2. Head measurements. Br J Obstet Gynaecol101: 35–438297866
39. Hadlock FP,, Harrist RB,, Sharman RS,, Deter RL,, Park SK, (Year: 1985) Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol151: 333–3373881966
40. Owen P,, Donnet ML,, Ogston SA,, Christie AD,, Howie PW,, et al. (Year: 1996) Standards for ultrasound fetal growth velocity. Br J Obstet Gynaecol103: 60–698608100
41. Ott WJ, (Year: 2002) Diagnosis of intrauterine growth restriction: comparison of ultrasound parameters. Am J Perinatol19: 133–13712012288
42. Lampl M,, Jeanty P, (Year: 2003) Timing is everything: a reconsideration of fetal growth velocity patterns identifies the importance of individual and sex differences. Am J Hum Biol15: 667–68012953179
43. de Jong CL,, Gardosi J,, Baldwin C,, Francis A,, Dekker GA,, et al. (Year: 1998) Fetal weight gain in a serially scanned high-risk population. Ultrasound Obstet Gynecol11: 39–439511194
44. Figueras F,, Gardosi J, (Year: 2011) Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol204: 288–30021215383
45. Shulman CE,, Graham WJ,, Jilo H,, Lowe BS,, New L,, et al. (Year: 1996) Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. Trans R Soc Trop Med Hyg90: 535–5398944266
46. Rijken MJ,, Papageorghiou AT,, Thiptharakun S,, Kiricharoen S,, Dwell SL,, et al. (Year: 2012) Ultrasound evidence of early fetal growth restriction after maternal malaria infection. PLoS ONE7: e3141122347473
47. Scifres CM,, Nelson DM, (Year: 2009) Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol587: 3453–345819451203
48. Rijken MJ,, Moroski WE,, Kiricharoen S,, Karunkonkowit N,, Stevenson G,, et al. (Year: 2012) Effect of malaria on placental volume measured using three-dimensional ultrasound: a pilot study. Malar J11: 522222152
49. Griffin JB,, Lokomba V,, Landis SH,, Thorp JM Jr,, Herring AH,, et al. (Year: 2012) Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study. Malar J11: 31922963509
50. Huynh BT,, Fievet N,, Briand V,, Borgella S,, Massougbodji A,, et al. (Year: 2012) Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration. PLoS ONE7: e3534222514730
51. Kalanda BF,, van BS,, Verhoeff FH,, Brabin BJ, (Year: 2005) Anthropometry of fetal growth in rural Malawi in relation to maternal malaria and HIV status. Arch Dis Child Fetal Neonatal Ed90: F161–F16515724042
52. Kalanda BF,, Verhoeff FH,, Chimsuku L,, Harper G,, Brabin BJ, (Year: 2006) Adverse birth outcomes in a malarious area. Epidemiol Infect134: 659–66616255832
53. Landis SH, Lokomba V, Ananth CV, Atibu J, Ryder RW et al. . (2008) Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo. Epidemiol Infect 1–11.
54. Ott WJ, (Year: 2006) Sonographic diagnosis of fetal growth restriction. Clin Obstet Gynecol49: 295–30716721108
55. Nahum GG,, Stanislaw H, (Year: 2003) Ultrasonographic prediction of term birth weight: how accurate is it?Am J Obstet Gynecol188: 566–57412592273
56. Scioscia M,, Vimercati A,, Ceci O,, Vicino M,, Selvaggi LE, (Year: 2008) Estimation of birth weight by two-dimensional ultrasonography: a critical appraisal of its accuracy. Obstet Gynecol111: 57–6518165393
57. Mirghani HM,, Weerasinghe S,, Ezimokhai M,, Smith JR, (Year: 2005) Ultrasonic estimation of fetal weight at term: an evaluation of eight formulae. J Obstet Gynaecol Res31: 409–41316176509


[Figure ID: pone-0053794-g001]
doi: 10.1371/journal.pone.0053794.g001.
Figure 1  Different growth patterns after a malaria infection.

The four individual growth patterns are superimposed on a weight chart developed from healthy pregnancies in the cohort [31]. Normal growth observed after an infection at gestational age (GA) 20+1 (panel A). Immediate effect observed after an infection at GA 20+1 with an initial decline in growth observed in the growth interval antenatal visit (ANV)2– ANV3 followed by persistently normal growth until delivery (panel B). Late effect observed after an infection at a GA 17+0 with normal growth until ANV4 and thereafter a decline in growth until delivery (panel C). Persistent effect observed after an infection at GA 19+6 with decline in growth throughout pregnancy (panel D). The solid vertical lines indicate the timing of the three ANV. In panel B the ANV2 occurred slightly delayed at a GA of 27+2. The solid black and grey lines represent the 90th, 50th, and 10th percentile.

[TableWrap ID: pone-0053794-t001] doi: 10.1371/journal.pone.0053794.t001.
Table 1  Characteristics of the 876 mother-newborn pairs eligible for analysis stratified by gravidity.
Primi- and secundigravidae (n = 398) Multigravidae (n = 478)
Total Median (range)/n (%) Total Median (range)/n (%)
GA at inclusion (days) 398 128 (42–168) 478 131 (50–168)
GA at inclusion <14 weeks 398 76 (19.1) 478 77 (16.1)
GA at 14–24 weeks 398 322 (80.9) 478 401 (83.9)
Age (y) 398 22 (14–37) 477 30 (19–47)
Education ≤primary level 396 305 (77.2) 474 451 (95.2)
Ethnicity Sambaa 398 183 (46.0) 477 244 (51.2)
Zigua 59 (14.8) 104 (21.8)
Pare 31 (7.8) 21 (4.4)
Bondei 18 (4.5) 17 (3.6)
Othera 107 (26.9) 91 (19.1)
Maternal height (cm) 395 158 (143–183) 476 157 (142–187)
Maternal weight at incl. (kg) 395 53 (37–126) 475 54 (37–100)
MUAC <23cm at inclusionb 397 49 (12.3) 477 31 (6.5)
Malaria during pregnancyc 398 48 (12.1) 478 24 (5.0)
Malaria before ANV2d 48 28 (58.3) 24 7 (29.2)
Median parasitaemia (IE/ul)d 32 2090 (89–390.749) 8 4163 (39–45.760)
Single malaria infectiond 48 39 (81.2)e 24 22 (91.7)f
Received IPTp≥2 times 398 383 (96.2) 478 463 (96.9)
Never used bednet 398 32 (8.0) 478 13 (2.7)
Maternal HIV infection 368 9 (2.5) 439 32 (7.3)
Male newborn 393 194 (49.4) 470 239 (50.9)
Placental weight (g)g 310 587±142 346 598±150

aOther include various ethnic groups representing <2% of the women (not stratified by gravidity).

bMUAC<23 cm was used as a marker for poor nutritional status [53].

cComparison of malaria prevalence using Chi2 test p<0.001.

dOnly includes malaria positive women.

e17% (8/48) had two infections and 2% (1/48) three infection.

f8% (2/24) had two infections.


Abbreviations: ANV = antenatal visit,, GA = gestational age, G = gram, HIV = human immunodeficiency virus, IE = infected erythrocytes, Incl. = inclusion, IPTp = intermittent preventive treatment in pregnancy, MUAC = mid upper arm circumference, N = number, ul = microliter, Y = year.

[TableWrap ID: pone-0053794-t002] doi: 10.1371/journal.pone.0053794.t002.
Table 2  Fetal weight, fetal growth, birth weight and gestational age at delivery.
Primi- and secundigravidae (n = 398) Multigravidae (n = 478)
n Median (range)/Mean±SD n Median (range)/Mean±SD
Fetal weight (g) ANV2 382 884 (605–1246) 461 883 (648–1253)
ANV3 376 1469 (1035–1942) 461 1481 (1124–2167)
ANV4 352 2575 (1894–3345) 440 2616 (1593–3340)
Fetal growth (g/week)a ANV2-3 365 146±23 443 151±23
ANV3-4 336 187±29 427 190±30
ANV4-Del 282 148±83 357 154±91
Birth weight (g)b Malaria pos. 37 2910 (2000–4000) 16 3415 (3000–3500)
Malaria neg. 298 3100 (1200–4500) 387 3180 (900–4510)
Z-score at Del.a, c Malaria pos. 36 −0.63±1.13 16 0.34±1.01
Malaria neg. 298 −0.06±1.08 383 0.02±1.09
GA at Del. (days)d Malaria pos. 47 278 (246–302) 24 280 (267–299)
Malaria neg. 348 280 (209–299) 453 280 (178–308)

aMean±SD (parametric distribution).

bMann-Whitney, comparison of malaria negative and positive, p = 0.005 for primi- and secundigravidae, p = 0.32 for multigravidae.

cStudents t-test, comparison of malaria negative and positive, p = 0.003 for primi- and secundigravidae, p = 0.26 for multigravidae.

dMann-Whitney, comparison of malaria negative and positive, no significant difference.

Abbreviations: ANV = antenatal visit, Del. = delivery, GA = gestational age, G = gram, N = number, Neg. = negative, Pos. = positive.

[TableWrap ID: pone-0053794-t003] doi: 10.1371/journal.pone.0053794.t003.
Table 3  The effect of malaria during pregnancy on fetal growth, given as relative fetal growth (g/week*kg), among primi- and secundigravidae.
Malaria positivea (n = 48) Malaria negativea (n = 350)
Total Median (95% CI) Total Median (95% CI) Pb
EFW at ANV2c 46 884 (861–903) 336 884 (874–897) 0.80
As g/week*kg ANV2-3 29 159 (151–177) 321 165 (161–170) 0.91
ANV3-4 32 121 (113–129) 296 130 (128–133) 0.046
ANV4-Del 27 40 (29–54) 253 57 (53–62) 0.017
ANV3-Del 30 94 (87–128) 281 119 (116–125) 0.006

aWomen were considered to be malaria negative if they never had malaria based on RDT and microscopy results from the time they were enrolled. Women, who contracted malaria, were considered to belong to the malaria group from when they were diagnosed until delivery. When investigating a particular growth interval, women who only contracted malaria after the particular growth interval were excluded from that specific analysis.

bMann Whitney test.

cThe malaria positive group include all women contracting malaria during pregnancy.

Abbreviations: ANV = antenatal visit, CI = confidence interval, Del = delivery N = number.

[TableWrap ID: pone-0053794-t004] doi: 10.1371/journal.pone.0053794.t004.
Table 4  Proportion of primi and secundigravidae with a fetal weight gain belonging to the lowest 25%, stratified by malaria positivity.
Malaria positivea (n = 48) Malaria negativea (n = 350)
Total % (95% CI) Total % (95% CI) Pb
Lowest 25% ANV2-3 29 26 (13–47) 321 24 (19–29) 0.67
ANV3-4 32 44 (26–62) 296 23 (18–28) 0.009
ANV4-Del 27 41 (22–61) 253 23 (18–29) 0.047
ANV3-Del 30 53 (34–72) 281 21 (17–27) <0.001

aWomen were considered to be malaria negative if they never had malaria based on RDT and microscopy results from the time they were enrolled. Women, who contracted malaria, were considered to belong to the malaria group from when they were diagnosed until delivery. When investigating a particular growth interval, women who only contracted malaria after the particular growth interval were excluded from that specific analysis.

bChi2 test.

Abbreviations: ANV = antenatal visit, CI = confidence interval, Del = delivery N = number.

[TableWrap ID: pone-0053794-t005] doi: 10.1371/journal.pone.0053794.t005.
Table 5  The effect of malaria among primi- and secundigravidae on z-score of birth weight, relative weight gain from ANV3 to ANV4, ANV4 to delivery, and ANV3 to delivery.
n Coeff./OR 95% CI P
Change in Z-score at deliverya 285 −0.50 −0.86, −.13 0.008
Relative weight gain belonging to lowest 25% (OR) ANV3-A4b 327 2.72 1.18, 6.23 0.019
ANV4- Delc 258 2.48 1.04, 5.91 0.040
ANV3- Deld 282 4.89 2.03, 11.79 <0.001

Coefficient and ORs adjusted for confounding factors. Relative weight gain was dichotomized as belonging to the lowest 25% or highest 75% of the distribution observed among primi- and secundigravidae.

aMultiple linear regression, adjusted for maternal weight at inclusion, maternal weight gain from inclusion-ANV3 (median gain 198 g/week, 95% CI: 170–230 g/week), maternal weight gain from ANV3-ANV4 (median gain 250 g/week, 95% CI: 168–326 g/week), placental weight, and place of delivery, 32 malaria positive and 253 malaria negative.

bMultiple logistic regression, adjusted for MUAC at inclusion and GA at ANV3, 32 malaria positive and 295 malaria negative.

cMultiple logistic regression, adjusted for placental weight, 25 malaria positive and 233 malaria negative women d) Multiple logistic regression, adjusted for GA at ANV3, GA at delivery, sex of newborn and placental weight, 28 malaria positive and 254 malaria negative.

Abbreviations: ANV = antenatal visit, CI = confidence interval, Coeff. = coefficient, Del = delivery N = number, OR = odds ratio.

[TableWrap ID: pone-0053794-t006] doi: 10.1371/journal.pone.0053794.t006.
Table 6  Patterns of fetal growth following a malaria infection evaluated using Δz for the individual offspring.
Primi- and secundi Multigravidae All
Type of growth Totala n (%) n (%) Median BW (g) (95% CI)
Normalb 21 11/37 (29.7) 10/15 (66.6) 3300 (2994–3500)
Abnormalc Immediate 12 10/37 (27.0) 2/15 (13.3) 2940 (2610–3490)
Lated 11 10/37 (27.0) 1/15 (6.7) 2850 (2579–3023)
Persistent 8 6/37 (16.2) 2/15 (13.3) 2705 (2338–3163)
Total 52 37 15

aOnly fetuses with data from at least two growth intervals and an eligible birth weight were included. Fifty-two of the 72 malaria exposed met these criteria. Forty had all three growth intervals available, one only ANV2-ANV4 and ANV4-Del, eight ANV2-ANV3 and ANV3-Del, and three ANV3-ANV4 and ANV4-Del.

bNormal growth = Δz ≥25th centile in all growth intervals following a malaria infection.

cImmediate effect = Δz <25th centile in the growth interval when the infection occurred or in the first growth interval after a malaria infection, followed by growth intervals where Δz ≥25th centile; Late effect = Δz<25th centile in a growth interval not immediately following the infection; Persistent effect = Δz <25th centile immediately after a malaria infection and until the end of pregnancy.

dThe effect was observed min. 6 weeks after the infection.

Abbreviation: BW = birth weight, CI = confidence interval, G = gram, N = number.

Article Categories:
  • Research Article
Article Categories:
  • Medicine
    • Clinical Research Design
      • Observational Studies
    • Global Health
    • Infectious Diseases
      • Parasitic Diseases
        • Malaria
          • Plasmodium Falciparum
      • Tropical Diseases (Non-Neglected)
        • Malaria
          • Plasmodium Falciparum
    • Obstetrics and Gynecology
      • Pregnancy
    • Pediatrics
      • Growth Retardation
    • Radiology
      • Diagnostic Radiology
        • Ultrasonography

Previous Document:  BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippo...
Next Document:  Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Strin...